| Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio … Developed with the Special Contribution of the European Association for ... European heart journal 31 (20), 2501-2555, 2010 | 3402 | 2010 |
| Assessment of the SYNTAX score in the Syntax study PW Serruys, Y Onuma, S Garg, G Sarno, M van den Brand, AP Kappetein, ... EuroIntervention 5 (1), 50-56, 2009 | 799 | 2009 |
| Comparison of zotarolimus-eluting and everolimus-eluting coronary stents PW Serruys, S Silber, S Garg, RJ van Geuns, G Richardt, PE Buszman, ... New England journal of medicine 363 (2), 136-146, 2010 | 782 | 2010 |
| Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy … P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ... The Lancet 392 (10151), 940-949, 2018 | 778 | 2018 |
| Coronary stents: current status S Garg, PW Serruys Journal of the American College of Cardiology 56 (10S), S1-S42, 2010 | 711 | 2010 |
| Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque PW Serruys, HM García-García, P Buszman, P Erne, S Verheye, ... Circulation 118 (11), 1172-1182, 2008 | 607 | 2008 |
| Stent thrombosis DR Holmes, DJ Kereiakes, S Garg, PW Serruys, GJ Dehmer, SG Ellis, ... Journal of the American College of Cardiology 56 (17), 1357-1365, 2010 | 537 | 2010 |
| Coronary stents: looking forward S Garg, PW Serruys Journal of the American College of Cardiology 56 (10S), S43-S78, 2010 | 397 | 2010 |
| Guidelines on myocardial revascularization. P Kolh, W Wijns, N Danchin, C Di Mario, V Falk, T Folliguet, S Garg, ... European Journal of Cardio-Thoracic Surgery 38, 2010 | 379 | 2010 |
| A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score S Garg, G Sarno, HM Garcia-Garcia, C Girasis, J Wykrzykowska, ... Circulation: Cardiovascular Interventions 3 (4), 317-326, 2010 | 354 | 2010 |
| 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo … PW Serruys, Y Onuma, S Garg, P Vranckx, B De Bruyne, MC Morice, ... Journal of the American College of Cardiology 55 (11), 1093-1101, 2010 | 322 | 2010 |
| Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled … CV Bourantas, YJ Zhang, S Garg, J Iqbal, M Valgimigli, S Windecker, ... Heart 100 (15), 1158-1164, 2014 | 306 | 2014 |
| Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial JJ Wykrzykowska, S Garg, C Girasis, T De Vries, MA Morel, GA Van Es, ... Journal of the American College of Cardiology 56 (4), 272-277, 2010 | 290 | 2010 |
| SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus … C Girasis, S Garg, L Räber, G Sarno, MA Morel, HM Garcia-Garcia, ... European heart journal 32 (24), 3115-3127, 2011 | 229 | 2011 |
| Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary … S Garg, G Sarno, PW Serruys, AE Rodriguez, L Bolognese, M Anselmi, ... JACC: Cardiovascular Interventions 4 (1), 66-75, 2011 | 225 | 2011 |
| Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study M Magro, S Nauta, C Simsek, Y Onuma, S Garg, E van der Heide, ... American heart journal 161 (4), 771-781, 2011 | 177 | 2011 |
| Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the ‘all-comers' leaders trial JJ Wykrzykowska, S Garg, Y Onuma, T de Vries, D Goedhart, MA Morel, ... Circulation: Cardiovascular Interventions 4 (1), 47-56, 2011 | 159 | 2011 |
| Ticagrelor alone versus dual antiplatelet therapy from 1 month after drug-eluting coronary stenting A Franzone, E McFadden, S Leonardi, R Piccolo, P Vranckx, PW Serruys, ... Journal of the American College of Cardiology 74 (18), 2223-2234, 2019 | 144 | 2019 |
| The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus-and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial S Garg, PW Serruys, S Silber, J Wykrzykowska, RJ van Geuns, G Richardt, ... JACC: Cardiovascular Interventions 4 (4), 432-441, 2011 | 143 | 2011 |
| New concepts in the design of drug-eluting coronary stents S Garg, C Bourantas, PW Serruys Nature Reviews Cardiology 10 (5), 248-260, 2013 | 142 | 2013 |
